Get the Stockscreener App
91.65
38.89%
-58.32
Pre-market:
93.00
1.35
+1.47%
Billiontoone Inc stock is traded at $91.65, with a volume of 3.74M.
It is down -38.89% in the last 24 hours and down -25.73% over the past month.
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.
See More
Previous Close:
$149.97
Open:
$105.16
24h Volume:
3.74M
Relative Volume:
5.26
Market Cap:
$4.22B
Revenue:
$354.54M
Net Income/Loss:
$23.65M
P/E Ratio:
198.08
EPS:
0.4627
Net Cash Flow:
-
1W Performance:
-34.34%
1M Performance:
-25.73%
6M Performance:
+1.15%
1Y Performance:
+0.00%
1-Day Range:
$90.12
$105.35
1-Week Range:
$90.12
$150.44
52-Week Range:
$61.96
$150.44
Billiontoone Inc Stock (BLLN) Company Profile
Name
Billiontoone Inc
Sector
Industry
Phone
650-460-2551
Address
1035 O'BRIEN DRIVE, MENLO PARK
Compare BLLN vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BLLN
Billiontoone Inc
|
91.65 | 5.89B | 354.54M | 23.65M | 0 | 0.4627 |
TMO
Thermo Fisher Scientific Inc
|
580.02 | 207.93B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
199.98 | 138.14B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
590.00 | 43.87B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
141.34 | 38.94B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
399.70 | 36.45B | 3.77B | 449.25M | 240.68M | 7.8556 |
Billiontoone Inc Stock (BLLN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-26 | Initiated | Guggenheim | Buy |
| Dec-01-25 | Initiated | BTIG Research | Buy |
| Dec-01-25 | Initiated | JP Morgan | Overweight |
| Dec-01-25 | Initiated | Jefferies | Hold |
| Dec-01-25 | Initiated | Piper Sandler | Overweight |
| Dec-01-25 | Initiated | Stifel | Buy |
| Dec-01-25 | Initiated | Wells Fargo | Equal Weight |
| Dec-01-25 | Initiated | William Blair | Outperform |
View All
Billiontoone Inc Stock (BLLN) Latest News
BillionToOne Inc (BLLN) Cash Flow - TradingKey
BillionToOne Inc (BLLN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BillionToOne Inc (BLLN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
BillionToOne Inc (BLLN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BillionToOne Inc (BLLN) Balance Sheet - TradingKey
BillionToOne Inc (BLLN) Valuation: PE, PB & Fair Value Analysis - TradingKey
BillionToOne Inc (BLLN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
BLLN|BillionToOne Inc|Price:126.080|Chg%:-2.860 - TradingKey
BillionToOne Inc (BLLN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
BillionToOne Inc (BLLN) Income Statement - TradingKey
BillionToOne, Inc. Revenue Breakdown – NASDAQ:BLLN - TradingView
BLLN|BillionToOne Inc|Price:128.580| - TradingKey
BillionToOne Inc (BLLN) Institutional Confidence - TradingKey
BillionToOne Inc (BLLN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BTIG Maintains BillionToOne(BLLN.US) With Buy Rating, Raises Target Price to $142 - Moomoo
BilliontoOne SVP Nancy Johnson sells $1.82m in stock - Investing.com UK
BilliontoOne SVP Nancy Johnson sells $1.82m in stock By Investing.com - Investing.com South Africa
Form 4 BillionToOne Inc For: 21 July By Investing.com - Investing.com South Africa
BillionToOne Insider Sold Shares Worth $1,821,628, According to a Recent SEC Filing - Moomoo
BillionToOne SVP Sales Nancy JoAnn Johnson disposes of 14,199 common shares worth $1.82 million - Bitget
BillionToOne, Inc. (BLLN) SVP sells 14,199 shares via Rule 10b5-1 plan - Stock Titan
Billiontoone (NASDAQ:BLLN) Trading Down 5.6%What's Next? - MarketBeat
BillionToOne names Ethan Dmitrovsky as oncology chief medical officer By Investing.com - Investing.com Nigeria
BillionToOne names Ethan Dmitrovsky as oncology chief medical officer - Investing.com India
BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar - PR Newswire
A BillionToOne Insider Sold 801 Shares as Revenue Jumped 84% - AOL.com
BillionToOne Announces Date for Second Quarter 2026 Financial Results Conference Call - Moomoo
Form 144 BillionToOne For: 16 July By Investing.com - Investing.com Canada
BLLN (NASDAQ: BLLN) holder Nancy Johnson reports Class A share sales - Stock Titan
Billiontoone Insider Sold Shares Worth $2,497,698, According to a Recent SEC Filing - Moomoo
BillionToOne CTO David Tsao sells $2.5m in company stock By Investing.com - Investing.com Australia
Insider Sell: ten Bosch John Roderick Sells Shares of BillionToO - GuruFocus
Billiontoone Insider Sold Shares Worth $533,330, According to a Recent SEC Filing - Moomoo
Form 4 BillionToOne Inc For: 15 July By Investing.com - Investing.com Nigeria
BillionToOne SVP John ten Bosch sells $533,330 in company stock By Investing.com - Investing.com South Africa
BillionToOne CTO David Tsao sells $2.5m in company stock - Investing.com
BillionToOne SVP John ten Bosch sells $533,330 in company stock - Investing.com
BillionToOne, Inc. (BLLN) SVP sells 4,251 shares under Rule 10b5-1 plan - Stock Titan
BillionToOne, Inc. (BLLN) CTO sells 20,000 shares and exercises options - Stock Titan
BillionToOne to Report Second Quarter 2026 Financial Results on August 5, 2026 - The Manila Times
Publicly held genetic testing firm sues Centene, alleging prenatal test reimbursement scheme - The Business Journals
IPOs juice biotech real estate (if only a little), but vacancy still climbs and lease rates tumble - The Business Journals
Billiontoone Insider Sold Shares Worth $1,576,276, According to a Recent SEC Filing - Moomoo
Billiontoone, Inc. $BLLN Shares Bought by Emerald Mutual Fund Advisers Trust - MarketBeat
Emerald Advisers LLC Buys 50,613 Shares of Billiontoone, Inc. $BLLN - MarketBeat
Billiontoone, Inc. (NASDAQ:BLLN) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Form 4 BillionToOne Inc For: 13 July By Investing.com - Investing.com Nigeria
BillionToOne CEO Oguzhan Atay sells $1.57m in company stock By Investing.com - Investing.com Australia
Billiontoone Inc Stock (BLLN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Billiontoone Inc Stock (BLLN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Atay Oguzhan | Chairman and CEO |
Aug 03 '26 |
Sale |
136.95 |
32,500 |
4,450,835 |
0 |
| Atay Oguzhan | Chairman and CEO |
Aug 03 '26 |
Sale |
137.37 |
12,500 |
1,717,125 |
162,500 |
1.13%
0.02%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):